300858 Beijing Scitop Bio-tech
- 13.34
- +0.08+0.60%
Beijing Scitop Bio-tech News
Beijing Scitop Bio-tech: Summary report of First Venture Securities Underwriting and Sponsorship Co., Ltd. on the initial public offering of shares of Beijing Ketuo Hengtong Biotechnology Co., Ltd. and its listing on GEM
Keto Biotech: 3-1 Supplemental Legal Opinion (1) (Revised Draft)
Ketuo Biotech: 2-1 Accountant's Response to the Audit Inquiry Letter of Beijing Ketuo Hengtong Biotechnology Co., Ltd.'s Application to Issue Shares to Specific Targets (Revised Draft)
Ketuo Biotech: 1-1 Issuer and Sponsor Agency Response Report on Beijing Ketuo Hengtong Biotechnology Co., Ltd.'s Application to Issue Shares to Specific Targets (Revised Draft)
Ketuo Biotech: 6-1 The issuer's financial report for the most recent year and its audit report and the most recent financial report (for the most recent financial report, please submit the recently announced financial report) (Report)
Keto Biotech: 4-1 Legal Opinion (Application Draft)
Keto Biotech: 3-3 Listing Sponsorship Letter (Application Draft)
Keto Biotech: 3-1 Securities Issuance Sponsorship Letter (Application Draft)
Keto Biotech: 1-1 Application Instructions (Application Draft)
Ketuo Biotech: Audit inquiry letter on Beijing Ketuo Hengtong Biotechnology Co., Ltd.'s application to issue shares to specific targets
Ketuo Biotech: 6-1 The issuer's financial report for the most recent year and its audit report and the most recent financial report (for the most recent financial report, please submit the recently announced financial report) (Report)
Keto Biotech: 4-1 Legal Opinion (Application Draft)
Keto Biotech: 3-3 Listing Sponsorship Letter (Application Draft)
Keto Biotech: 3-1 Securities Issuance Sponsorship Letter (Application Draft)
Keto Biotech: 1-1 Application Instructions (Application Draft)
Keto Biotech: 2021 Annual Equity Distribution Implementation Notice
Announcement on the listing and trading of Beijing Ketuo Hengtong Biotechnology Co., Ltd. shares on the GEM
Keto Biotech: China Securities Regulatory Commission\'s approval for the company\'s initial public offering of shares
No Data